Get the Stockscreener App
3.62
2.43%
-0.09
Galectin Therapeutics Inc Stock (GALT) Forecast
The Galectin Therapeutics Inc (GALT) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $3.2204, representing a -11.04% decrease from the current price of $3.62. The highest analyst price target is $3.7002, and the lowest is $2.7407.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month GALT Price Target
Average 2.6121
(-27.84% Downside)
Is Galectin Therapeutics Inc (GALT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 43.62 | Neutral |
| STOCH(9,6) | 44.47 | Neutral |
| STOCHRSI(14) | 16.52 | Buy |
| MACD(12,26) | -0.0547 | Sell |
| ADX(14) | 13.97 | Neutral |
| William %R | -79.83 | Neutral |
| CCI(14) | -69.98 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.722
Sell
|
3.7314
Sell
|
| MA20 |
3.8305
Sell
|
3.7859
Sell
|
| MA50 |
3.8192
Sell
|
3.7768
Sell
|
| MA100 |
3.6401
Sell
|
3.6357
Sell
|
| MA200 |
3.2127
Buy
|
3.5836
Buy
|
Buy: 2
Sell: 8
Neutral: 0
Summary: Sell
According to our latest analysis, GALT could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 9 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on GALT, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 43.62 indicates that GALT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 44.47 indicates that GALT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 16.52 indicates that GALT is oversold. This suggests that GALT price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 13.97 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -69.98 indicates that GALT is still oversold but not to an extreme extent.
Long-term GALT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Galectin Therapeutics Inc financial reports and earnings history, Galectin Therapeutics Inc (GALT) stock could reach $3.319 by 2030, $3.0047 by 2040 and $3.3874 by 2050. See the projected annual prices until 2050 of the Galectin Therapeutics Inc stock below:
- Galectin Therapeutics Inc (GALT) is expected to reach an average price of $2.3807 in 2035, with a high prediction of $2.5498 and a low estimate of $2.2807. This indicates an $-34.23% rise from the last recorded price of $3.62.
- Galectin Therapeutics Inc (GALT) stock is projected to chart a bullish course in 2040, with an average price target of $2.6547, representing an $-26.67% surge from its current level. The forecast ranges from a conservative $2.3033 to a sky-high $3.0047.
- Our analysts predict Galectin Therapeutics Inc (GALT) to jump -30.36% by 2045, soaring from $2.4211 to an average price of $2.521, potentially reaching $2.7292. While $2.4211 is the low estimate, the potential upside is significant.
- Galectin Therapeutics Inc (GALT) stock is expected to climb by 2050, reaching an average of $2.9896, a $-17.41% jump from its current level. However, a wide range of estimates exists, with high and low targets of $3.3874 and $2.8596, respectively, highlighting the market's uncertainty.
Galectin Therapeutics Inc Stock (GALT) Year by Year Forecast
Galectin Therapeutics Inc Stock (GALT) Price Forecast for 2026
The predicted value for Galectin Therapeutics Inc (GALT) in 2026 is set at an average of $3.7875. Estimates vary from a peak of $5.55 to a trough of $2.025, indicating an +4.63% surge from the present price of $3.62.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $2.9607 | $2.7407 | $3.7002 | -18.21% |
| December, 2026 | $2.7011 | $2.401 | $3.0007 | -25.38% |
Galectin Therapeutics Inc Stock (GALT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Galectin Therapeutics Inc (GALT) is $2.2145, with a high forecast of $2.9052 and a low forecast of $1.5239. This indicates an -38.82% decrease from the last price of $3.62.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.2516 | $2.2416 | $2.8012 | -37.80% |
| February, 2027 | $2.412 | $2.0417 | $2.532 | -33.37% |
| March, 2027 | $2.0926 | $2.0825 | $2.4821 | -42.19% |
| April, 2027 | $1.913 | $1.913 | $2.2827 | -47.15% |
| May, 2027 | $1.7952 | $1.7636 | $2.1033 | -50.41% |
| June, 2027 | $1.624 | $1.5239 | $1.7837 | -55.14% |
| July, 2027 | $1.5945 | $1.5245 | $2.0842 | -55.95% |
| August, 2027 | $2.185 | $1.5346 | $2.2004 | -39.64% |
| September, 2027 | $2.3355 | $2.2152 | $2.9052 | -35.48% |
| October, 2027 | $2.1459 | $1.9759 | $2.4156 | -40.72% |
| November, 2027 | $1.9565 | $1.7865 | $2.2361 | -45.95% |
| December, 2027 | $1.677 | $1.607 | $2.0216 | -53.68% |
Galectin Therapeutics Inc Stock (GALT) Price Forecast for 2028
In 2028, Galectin Therapeutics Inc (GALT) is projected to reach an average price of $2.0836, with a high projection of $2.8092 and a low estimate of $1.358. This indicates an -42.44% fall from the last price of $3.62.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.5575 | $1.4671 | $1.7173 | -56.97% |
| February, 2028 | $1.468 | $1.358 | $1.6684 | -59.45% |
| March, 2028 | $1.4484 | $1.4081 | $1.5581 | -59.99% |
| April, 2028 | $1.8889 | $1.4485 | $2.2288 | -47.82% |
| May, 2028 | $2.2994 | $1.899 | $2.8092 | -36.48% |
| June, 2028 | $2.3499 | $2.2395 | $2.5996 | -35.09% |
| July, 2028 | $2.0904 | $1.9602 | $2.39 | -42.25% |
| August, 2028 | $1.8786 | $1.8507 | $2.2505 | -48.11% |
| September, 2028 | $1.8013 | $1.6211 | $1.911 | -50.24% |
| October, 2028 | $1.7919 | $1.6919 | $2.3216 | -50.50% |
| November, 2028 | $2.0923 | $1.712 | $2.1323 | -42.20% |
| December, 2028 | $2.0928 | $1.9826 | $2.3427 | -42.19% |
Galectin Therapeutics Inc Stock (GALT) Price Forecast for 2029
The 2029 price forecast for Galectin Therapeutics Inc Stock (GALT) is $3.2572 on average, with a high prediction of $4.6149 and a low estimate of $1.8996. This represents an -10.02% decrease from the previous price of $3.62.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.3334 | $2.1129 | $2.623 | -35.54% |
| February, 2029 | $2.3038 | $2.1438 | $2.4438 | -36.36% |
| March, 2029 | $2.2442 | $2.1839 | $2.4639 | -38.00% |
| April, 2029 | $2.1848 | $1.8996 | $2.2748 | -39.65% |
| May, 2029 | $2.1053 | $1.9851 | $2.2049 | -41.84% |
| June, 2029 | $2.3007 | $1.9354 | $2.3457 | -36.44% |
| July, 2029 | $2.7363 | $2.2408 | $2.8262 | -24.41% |
| August, 2029 | $3.7967 | $2.6064 | $4.6149 | +4.88% |
| September, 2029 | $3.5772 | $3.0972 | $4.1268 | -1.18% |
| October, 2029 | $2.6877 | $2.6227 | $3.6273 | -25.75% |
| November, 2029 | $2.7682 | $2.348 | $3.2682 | -23.53% |
| December, 2029 | $2.6687 | $2.3287 | $3.0484 | -26.28% |
Galectin Therapeutics Inc Stock (GALT) Price Forecast for 2030
Galectin Therapeutics Inc Stock (GALT) is expected to reach an average price of $2.6674 in 2030, with a high forecast of $4.2577 and a low forecast of $1.077. This signifies an -26.32% decrease from the last price of $3.62.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $3.2192 | $2.5989 | $3.319 | -11.07% |
| February, 2030 | $3.1696 | $2.8994 | $3.5096 | -12.44% |
| March, 2030 | $2.8201 | $2.8001 | $3.2397 | -22.10% |
| April, 2030 | $3.2406 | $2.8002 | $3.5204 | -10.48% |
| May, 2030 | $1.5011 | $1.077 | $3.3108 | -58.53% |
| June, 2030 | $1.5915 | $1.2912 | $1.7385 | -56.03% |
| July, 2030 | $1.8421 | $1.4617 | $1.9821 | -49.11% |
| August, 2030 | $1.9426 | $1.7622 | $2.1474 | -46.34% |
| September, 2030 | $1.7331 | $1.4729 | $2.1734 | -52.12% |
| October, 2030 | $1.7336 | $1.5833 | $1.9826 | -52.11% |
| November, 2030 | $1.674 | $1.5637 | $1.9037 | -53.76% |
| December, 2030 | $2.5346 | $1.6345 | $4.2577 | -29.98% |
4.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):